We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Revive

News List

Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer firstwordpharma
August 18, 2021
Revive Therapeutics Ltd. ("Revive" or the "Company") is pleased to announce that Revive has entered into an exclusive license agreement (the "Agreement") with Puerto Rico Science Technology and Research Trust ("PRSTRT")
Revive Therapeutics, UCSF partner to study Bucillamine for severe Covid-19 pharmaceutical-business-review
May 08, 2021
Specialty life sciences company Revive Therapeutics has signed a research agreement with University of California, San Francisco (UCSF) to study Bucillamine as a potential treatment for severe Covid-19.